Tag: "statins"

Speaking Out Against The Mainstream’s Misleading Pro-Statin Message

| March 28, 2014 | Comments (0)

Recently, the issue of statin side-effects has been covered repeatedly in the media. Quite-prominent doctors and researchers have expressed their concerns regarding statin safety. In response, perhaps, we have seen some stout support for statins, including from Professor Rory Collin – co-director of a research group known as the Cholesterol Treatment Trialists (CTT) collaboration. In [...]

Read More

Doctor Speaks Out Against “Statins For All” Policy

| March 10, 2014 | Comments (0)

The National Institute for Health and Care Excellence (NICE) in the UK has recently put forward the idea that the number of people treated with statins should be widened considerably. Currently, doctors in the UK are recommended to treat individuals estimated to have a 20 per cent risk of developing cardiovascular disease over the next [...]

Read More

Patients Should Be Made Aware Of The True Risk To Benefit Ratio Of Statins

| March 3, 2014 | Comments (1)

Moves are afoot which will mean that many more individuals will be considered as good candidates for statin therapy. One approach doctors use to communicate the benefits of statins is to say that they will reduce the risk of heart attack by a third, for example. But this can be very misleading, as the true [...]

Read More

Drive To Put More People On Statins Intensifies

| February 13, 2014 | Comments (0)

Yesterday, the National Institute for Health and Care Excellence (NICE) published draft proposals concerning the use of statins for the prevention of cardiovascular disease. Previously, NICE advised doctors to recommend treatment in those with a calculated 10-year risk of cardiovascular disease of 20 per cent or more. Now, NICE is proposing that this threshold will [...]

Read More

Why A Recent BMJ Article On Statins Reeks Of Bias

| February 6, 2014 | Comments (0)

On 27th January, the British Medical Journal (BMJ) published an article on the benefits and risks of taking cholesterol-lowering statins. It was co-authored by two researchers from the ‘Cochrane Collaboration’ [1] (an international collective of researchers whose self-proclaimed role is to provide accurate and robust assessments of health interventions. The group specialises in ‘meta-analyses’: the [...]

Read More

Copy Protected by Chetans WP-Copyprotect.